AHR and cardiac hypertrophy: In cardiac hypertrophy models triggered by isoproterenol (ISO) and aryl hydrocarbon receptor (AhR) activation, increased CYP4A/4F enzyme expression elevates 20-HETE levels, and inhibiting its synthesis significantly mitigates hypertrophy19,20.